국내 침습성 폐렴사슬알균 감염증의 임상양상
Clinical Features of Invasive Pneumococcal Disease in Korea
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background: Streptococcus pneumoniae is one of the most important causes of pneumonia, meningitis, bacteremia, and other invasive diseases in children and adults. The 23-valent polysaccharide pneumococcal vaccine (PPV) has been recommended to adults with high risk conditions by the Korea Society of Infectious Diseases in 2007, but there is no data on the epidemiology of invasive pneumococcal disease in Korean adults to support this recommendation. Therefore, we performed a study to investigate the epidemiology of invasive pneumococcal disease in Korean population. Materials and Methods: We collected clinical and microbiologic data of patients diagnosed with invasive pneumococcal disease (IPD) in 3 universityhospitals located in Seoul and Gyeonggi-do from January 2002 to December 2007. Results: A total of 168 patients were diagnosed with IPD in the selected hospitals during the study period. Invasive pneumonia and meningitis were the most common forms of IPDs. The mean length of hospitalization of patients with IPD was 18.5±26.7 days and mortality rate of IPD was 18.6%. Among the isolates from patients with IPD, 59.7% was susceptible to penicillin and 38.3%was susceptible to erythromycin. Mortality rate of IPD increased with age and in patients with Eastern Cooperative Oncology Group performance status 4. Conclusions: Epidemiology of IPD in Korean population was described. Further studies should be performed to secure the risk factors of invasive pneumococcal diseases and to confirm the appropriateness of recommendation for vaccination with the 23-valent PPV.
Abstract
Background: Streptococcus pneumoniae is one of the most important causes of pneumonia, meningitis, bacteremia, and other invasive diseases in children and adults. The 23-valent polysaccharide pneumococcal vaccine (PPV) has been recommended to adults with high risk conditions by the Korea Society of Infectious Diseases in 2007, but there is no data on the epidemiology of invasive pneumococcal disease in Korean adults to support this recommendation. Therefore, we performed a study to investigate the epidemiology of invasive pneumococcal disease in Korean population. Materials and Methods: We collected clinical and microbiologic data of patients diagnosed with invasive pneumococcal disease (IPD) in 3 universityhospitals located in Seoul and Gyeonggi-do from January 2002 to December 2007. Results: A total of 168 patients were diagnosed with IPD in the selected hospitals during the study period. Invasive pneumonia and meningitis were the most common forms of IPDs. The mean length of hospitalization of patients with IPD was 18.5±26.7 days and mortality rate of IPD was 18.6%. Among the isolates from patients with IPD, 59.7% was susceptible to penicillin and 38.3%was susceptible to erythromycin. Mortality rate of IPD increased with age and in patients with Eastern Cooperative Oncology Group performance status 4. Conclusions: Epidemiology of IPD in Korean population was described. Further studies should be performed to secure the risk factors of invasive pneumococcal diseases and to confirm the appropriateness of recommendation for vaccination with the 23-valent PPV.
참고문헌 (24)
- Laurichesse H, "Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dome, France, 1994-1998", Eur J Clin Microbiol Infect Dis, 20, pp.299~308 (2001)
- Ma JS, "Clinical outcome of invasive pneumococcal infection in children: a 10-year retrospective analysis", J Microbiol Immunol Infect, 35, pp.23~28 (2002)
- Hsu LY, "Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore", J Med Microbiol, 58, pp.101~104 (2009)
- Ispahani P, "Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation", Arch Dis Child, 89, pp.757~762 (2004)
- Lee HJ, "High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea", Clin Infect Dis, 20, pp.826~835 (1995)
- Kim SN, "High incidence of multidrug-resistant Streptococcus pneumoniae in South Korea", Microb Drug Resist, 2, pp.401~406 (1996)
- Song JH, "Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)", J Antimicrob Chemother, 53, pp.457~463 (2004)
- Song JH, "High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)", Antimicrob Agents Chemother, 48, pp.2101~2107 (2004)
- Korea Center for Disease Control and Prevention, "Epidemiology and prevention of vaccine-preventable disease" (2006), Korea Center for Disease Control and Prevention
- Moberley SA, "Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;CD000422", ~ (2008)
- Conaty S, "The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials", Vaccine, 22, pp.3214~3224 (2004)
- Mangtani P, "Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence", Lancet Infect Dis, 3, pp.71~78 (2003)
- Møller K, "Is polysaccharide pneumococcal vaccine effective in adults?", Ugeskr Laeger, 163, pp.6112~6117 (2001)
- World Health Organization(WHO), "23-valent pneumococcal polysaccharide vaccine: WHO position paper", Wkly Epidemiol Rec, 83, pp.373~384 (2008)
- Choi EH, "Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children", Clin Infect Dis, 26, pp.1346~1354 (1998)
- 송은경, "소아 침습성 폐구균 감염증의 역학적 특성과 임상 양상", 소아감염, 12(2), pp.140~148 (2005), 한국소아감염병학회
- The Korean Society of Infectious Diseases, "Vaccination for adult" (2007), Koonja Publishing Co.
- Dominguez A, "The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study", Vaccine, 20, pp.2989~2994 (2002)
- Korea Center for Disease Control and Prevention, "Disease burden of pneumococcal infection and serotypes of Streptococcus pneumoniae in Korean children" (2006), Korea Center for Disease Control and Prevention
- Korean Ministry of Health and Welfare, "The third Korean national health and nutrition examination survey (KNHANES III) 2005" (2006), Korea Ministry of Health and Welfare
- Ardanuy C, "Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007", Clin Infect Dis, 48, pp.57~64 (2009)
- Tsai CJ, "Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States", Clin Infect Dis, 46, pp.1664~1672 (2008)
- Lexau CA, "Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine", JAMA, 294, pp.2043~2051 (2005)
- Performance standards for antimicrobial susceptibility testing, "Wikler MA", CLSI, ~, pp.CLSI document M100-S18 (2008)